Vonovia stock falls as Exane cuts its price target

Vonovia stock traded at EUR 17.18 on Xetra on September 22, 2026, while the shares remained close to the 52-week low of EUR 17.154. The immediate pressure came from Exane BNP cutting its price target from EUR 19 to EUR 16 and assigning an Underperform rating on September 22, 2026.

Exane target moves below the market

According to Goldesel on September 22, 2026, Exane BNP reduced its target by EUR 3, from EUR 19 to EUR 16. The new target is EUR 1.18 below the Xetra quotation of EUR 17.18, a gap of about 6.9 percent.

The target reduction adds to an earlier downgrade by Goldman Sachs. As Ad Hoc News reported on September 21, 2026, Goldman Sachs analyst Jonathan Kownator lowered the rating from Buy to Neutral on September 7 and reduced the price target from EUR 29.50 to EUR 21.20.

Guidance still sets the floor

Vonovia management is maintaining its 2026 adjusted EBITDA guidance of EUR 2.95 billion to EUR 3.05 billion, according to Ad Hoc News on September 21, 2026. The same report said reaching the upper end could be difficult because of weakness in the sales segments.

That guidance range is the key operating comparison in the current debate: the difference between its lower and upper ends is EUR 100 million, while the latest analyst target of EUR 16 is below the market quotation. For investors, the combination points to valuation pressure being linked not only to interest rates but also to the execution of property sales.

Stock stays near yearly low

Vonovia closed at EUR 17.79 on September 18, 2026, and was down 28 percent year to date, according to Ad Hoc News. The shares then reached a fresh 52-week low of EUR 17.55 on September 15, before the Xetra market data cited a low of EUR 17.154 on September 22.

Vonovia stock was quoted at EUR 17.18 on Xetra on September 22, 2026. The primary listing uses the ticker VNA and the reference currency EUR.

More news and analyses on Vonovia stock